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1.Introduction 
Atrial fibrillation (AF) is one of the most common tachyarrhythmias, with an incidence that 
continues, especially among the elderly where it affects upto 7% of the population. Due to 
the associated morbidities, including the risk of stroke, heart failure and impaired quality of 
life, numerous modalities have emerged for the treatment of atrial fibrillation. In recent 
years, an increasing number of patients are being treated with catheter ablation in an effort 
to restore sinus rhythm and decrease the associated co-morbidities. Compared to other 
treatment modalities, primarily that of pharmacotherapy, ablation of AF offers the unique 
opportunity to restore sinus rhythm and its associated benefits without the associated risks 
of anti-arrhythmic medications. These benefits, however, must be weighed against the 
known risks of ablation, which include perforation, cardiac tamponade, pulmonary vein 
stenosis and esophageal injury. It has been well described previously that premature atrial 
contractions (PACs) originating from the pulmonary veins are an important trigger for the 
initiation of AF. The sources of these PAC s are believed to be related to the presence of left 
atrial myocardial tissue that extends into the pulmonary vein. Consequently, most ablation 
strategies attempt to achieve electrical isolation of the pulmonary veins for the treatment of 
paroxysmal AF. Different energy sources combined with innovative catheter technologies 
are likely to improve the success rates of AF ablation. 
2. Radiofrequency lesions 
Radiofrequency (RF) energy is currently the most widely used energy source for 
performing catheter ablation procedures. RF generators deliver alternating current at 
frequencies too high to depolarize the myocardium between 500 and 1000 KHz (Haines 
1993 and Skanes et al 2003).  When using a 4mm catheter ablation tip, the radiofrequency 
energy used (20 to 50 W) is often generated from a 550 KHz electrosurgical unit and is 
delivered for 30-120 seconds (Manolis et al 1994).  Most commonly the RF power is 
delivered between a 8F 4-8mm catheter ablation tip and a dispersive reference patch 
applied to the skin. The application of RF energy between the small ablation tip and the 
dispersive electrode results in the greatest resistance to the current flow at the catheter tip 
to tissue interface. This results in resistive heating, and consequently leads into lesion 
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formation at the catheter to tissue interface. Deep tissue heating is consequence of 
conductive heating which is responsible for deep lesion formation. Conductive heating 
diminishes as a function of 1/r4 where  ‘r’ equals the distance from the point of maximal 
resistive heating (Hoffmann et al 1992 and Avitall et al 2004). Tissue temperatures above 
45 °C result in increase in cytosolic calcium concentration due to increased permeability, 
while sarcoplasmic ATPase is inhibited at temperatures above 50°C.  Above 50°C, 
irreversible tissue damage has been documented (Haines DE 1993 and Inesi et al 1973). At 
60°C, collagen denaturation occurs, with loss of elasticity and compliance of the ablated 
tissues. 
2.1 RF ablation non irrigated tip catheter 
The depth of lesion size increases as the temperature increase at the interface up to 100˚C.  
Above this temperature, the plasma starts boiling resulting in coagulum formation at the tip. 
This can lead to clot embolization, a sudden increase in impedance, loss of thermal 
conductivity, and ineffective tissue heating. Non-irrigated catheters are available with 4-
5mm and 8mm length tip ablation electrodes with an integrated thermocouple to monitor 
the tip temperature. With the 8mm catheter, a large portion of the electrode is exposed to 
flowing blood which cools the tip allowing for the application of higher RF power and the 
creation of larger lesions. 
A thermocouple is integrated at the tip for monitoring the temperature during ablation. The 
new generation RF generators can help to titrate the power up and down until the desired 
tip temperature is reached. This is called temperature guided RF ablation (Skanes et al, 
2003). Nowadays the generators are capable of opting between temperature guided or 
power guided RF ablation. The risk of a thromboembolism after LARFA (Left atrial 
radiofrequency ablation) is 1.1%, with most events occurring within 2 weeks after the 
procedure using 8mm tip catheter. (Oral et al 2006) 
2.2 Irrigated tip electrode catheter 
The irrigated tip electrode catheter (Figure 1) has 4-5mm ablation electrode. The presence of 
irrigation helps to keep the temperature at the tissue-electrode interface lower, thereby 
permitting improved delivery of RF energy to deeper tissues. Ultimately, this can facilitate 
the creation of more complete, and transmural, radiofrequency lesions. Additionally, 
irrigation at the site of ablation has also helped to minimize thrombus formation at the 
ablation site as well. The saline used for irrigation can be circulated within the electrode 
(closed loop system),  or open irrigation system that flushes saline through openings in the 
ablation electrode (Budde et al 1987, Grumbrecht et al 1998, Kongsgaard et al 1997, 
matsudairi et al 2003, Nakagawa et al 1998, Wittkampf et al 1989 and Yokoyama et al 2006). 
A major limitation of this catheter is the poor correlation of the tip temperature with the 
tissue temperature, often resulting in RF being curtailed and therefore incomplete lesions 
are made. The incidence of silent thromboembolic event in post ablation atrial fibrillation 
patients is 8.3% in irrigated tip catheter, 38.9% in duty cycled multielectrode catheter and 
5.6% in cryoballoon (Gaita et al 2011).  The duty cycled and cryoballoon ablation catheters 
have further been explained in the chapter. 
www.intechopen.com
Past, Present and Future Catheter Technologies  




Fig. 1. Irrigated closed loop and open irrigation electrode catheter (Yokoyama et al 2006). 
3. Irrigated tip catheter with contact sensor 
RF ablation is dependent on good tissue contact where the ablation electrode is firmly 
embedded in the targeted tissue. The contact angle and the force between the tip of the 
catheter and the tissue surface play a major role in the characteristics of the lesion. Irrigated 
tip catheters with contact sensors can be used to estimate the contact force and angle (Figure 
2). The catheter tip in this case is equipped with a deformable body that makes contact with 
the myocardial tissue. When subject to contact forces exerted by the tissue, the deformable 
body translates these forces into changes in wavelengths by optical fibers present within the 
catheter. Ultimately, these changes in wavelength are transformed via a computer algorithm 
to display both catheter vectors as well as contact force. The benefit of this catheter is that 
the combination of appropriate angle and force can be used to generate maximum 
transmurality with minimum incidence of steam pop and thrombus formation. (Schmidt et 
al 2009) 
4. Spiral catheter 
Another example of a catheter that is designed to specifically isolate the pulmonary vein 
(PV) Ostia resembles a corkscrew shape (Figure 3). This catheter is equipped with four 12 
mm coil electrodes, with two thermistors placed at the edges of each coil to regulate the RF 
power, adjusting to the maximal sensed temperature from each thermistor (Avitall et al 
2005). Standard radiofrequency generator with specialized interface was used. 
The ablation catheter is introduced into the PVs via a 9F sheath.  Once the tip of the catheter 
is in the PV, the sheath is withdrawn while maintaining the catheter position in the PV. As 
shown below, the spiral catheter expands within the vein and the coil electrodes are 
embedded within and under the orifice of the PV [figure 4]. Prior studies using this catheter 
demonstrated no visible PV narrowing during final PV angiography. PV circumferential 
lesions were documented in PVs and no PV stenosis was documented. One drawback 
however was the requirement to rotate the catheter position to create a circumferential 
lesion. 
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Fig. 2. Irrigated tip catheter with Contact sensor (Yokoyama et al 2008). 
      
Fig. 3. PV ostia spiral catheter (Avitall et al 2005). 
.  
Fig. 4. Spiral catheter in Pulmonary veins, the spiral catheter expands within the vein and 
the coil electrodes are embedded within and under the orifice of the PV. 
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5. The duty cycled multi electrode catheter 
The pulmonary vein ablation catheter (PVAC) or duty cycled multi electrode catheter 
(Ablation Frontiers, Inc., Carlsbad, CA, USA) is a 9F, over-the-wire, circumlinear (diameter 
25mm), decapolar mapping and ablation catheter (Figure 5). The 3mm long platinum 
electrodes have an outer diameter of approximately 1.5mm and are spaced 3mm apart. Each 
electrode contains a thermocouple positioned on the surface contact side of the electrode. 
The catheter has 2 control handles.  One allows bidirectional deflection of the shaft and the 
other is used to move the distal tip forward along the 0.032 mm guidewire, allowing a 
change of the catheter from its circular shape to a spiral configuration and finally to a 
longitudinal shape.  The catheter is advanced through the sheath in its longitudinal shape 
and then deployed in the atria with the guidewire positioned in the vein (Boersma et al 
2008). The GENius RF generator (Ablation Frontiers, Inc., Carlsbad, CA, USA) is a 
multichannel, dutycycled RF generator capable of independently delivering energy 
simultaneously to a maximum of 12 electrodes.  RF energy can be delivered in unipolar 
(between ablation electrode and reference patch) and bipolar (between 2 adjacent ablation 
electrodes) configurations.  Pairs of electrodes can be selected independently.  During RF 
application, energy delivery is controlled by a software algorithm that modulates power to 
reach the user-defined target temperature (60˚C), but always limits power to a maximum of 
10W per electrode. In this way, the ablation is “temperature controlled”. Although this 
ablation technology limits the peak power to 10W, lower than with a non-irrigated 4 mm tip 
catheter, the current density applied at the tissue surface is approximately the same due to 
the smaller surface area of the electrodes. One limitation however is that achieving PV 
isolation requires rotation of the catheter to create overlapping circumferential lesions 
(Boersma et al 2008). Boersma et al studied 98 patients with paroxysmal or persistent AF to 
evaluate the feasibility and safety of this multielectrode catheter. All targeted PVs were 
isolated using this catheter, and follow-up after 6 months without antiarrhythmic drugs 
showed freedom from AF in 83% of patients. This study also demonstrated that fluoroscopy 
and procedural time appear to be shorter than those associated with current AF ablation 
techniques, without the need for sophisticated mapping and/or steering modalities (Wijffels 
et al 2009). 
 
Fig. 5. PVAC (Decapolar Mapping and Ablation Catheter) (Wijffels et al.).   
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6. Loop catheter 
The loop catheter design for the creation of linear lesions in an effort to ablate AF was 
introduced in 1997.  There are two main loop catheter systems, mostly used for experimental 
studies (Boston Scientific, EP Technologies, Sunnyvale, CA, USA) (Avitall et al 1999). Both 
catheter designs are shown in Figure 6.  The first catheter system has twenty four 4mm ring 
electrodes that can create loops in the atria. In an effort to increase the efficiency of the 
ablation system, the second loop catheter was designed with fourteen 12-mm long coil 
electrodes 2 mm apart, equipped with two thermistors that were positioned at the two edges 
of each coil.  The power is regulated to the maximal temperature measured between the two 
thermistors. Depending on the magnitude of the pullwire retraction and the size of the 
catheter portion extending from the sheath, the electrode portion of the catheter can form 
loops of various sizes. The body of the catheter applies pressure on the thin atrial walls and 
forces them to stretch around the catheter, maintaining consistent electrode–tissue contact 
along the entire length of the ablation portion of the catheter. Since the forces that are 
applied to the atrial walls are distributed along the catheter shaft around the loop, it is 
presumed that no single point is exposed to excessive forces. A locking mechanism holds 
the catheter and pullwire firmly in position. (Avitall et al 2002). 
The most important determinant in the effective creation of a RF lesion is the electrode–
tissue contact. Using the variable loop concept, the globular shaped atrial chambers will 
adapt around the catheter providing continuous contact. When using temperature control 
with this technology, over 90% of the lesions created in both atria were both contiguous and 
transmural while minimizing the incidence of significant rises in impedance.  The catheter 
can be used to create linear lesions 6 mm wide and up to 16 cm long with minimal 
manipulation.  Linear lesions were made by ablating at individual electrodes. Having 
multiple ablation electrodes on a single shaft allows for minimal catheter manipulation in 
creating long linear lesions and, therefore, may reduce both thromboembolic risk and 
radiation exposure. Once the catheter is in place, it remains in position for the duration of 
the power application to all of the electrodes (Avitall et al 2002). 
 
Fig. 6. The loop catheter system. (A) 8F with 24 4-mm-long ring electrodes spaced 4 mm 
apart. (B) 8F with 14 12-mm-long coil electrodes spaced 2-mm apart.  A soft, braided pull 
wire attached to the distal tip of the catheter can be retracted into the long guiding sheath to 
deflect the catheter tip to create a loop of various sizes. (Avitall et al 1999).  
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7. Laser AF ablation 
A laser is a device that emits light (electromagnetic radiation) through a process of optical 
amplification based on the stimulated emission of photons. Emitted laser light is notable 
for its high degree of spatial and temporal coherence, unattainable using other 
technologies. Since duration and intensity of a laser can be controlled, it penetrates the 
tissue and scatters after getting absorbed in the tissue. Photon energy causes the 
vibrational excited state of surrounding molecules. This leads to generation of heat 
resulting in lesion creation. Laser energy can create deeper lesions with less reliance on 
thermal diffusion and can reduce tissue vaporization and coagulum formation. Because of 
its focused nature, it minimizes the collateral atrial tissue damage (Littman et al 1993). 
Two types of laser namely, Nd- YAG  and Diode laser have been used in clinical 
application. Between them Diode laser with a wavelength of 980 nm, can minimize 
endocardial disruption. (Littman et al 1993) 
7.1 Visually guided Laser balloon catheter  
Identification of the left atrial-pulmonary vein junction remains challenging, and 
additionally, creating contiguous lesions in a point by point manner to isolate the 
pulmonary veins (PV) is quite difficult. Balloon catheters provide an advantage in 
overcoming the challenge of charring and clot formation allowing for more precise lesion 
creation (Reddy et al 2004). The visually guided balloon catheter (Figure 7a) has an optic 
fiber head at the proximal end of the balloon and is equipped with an endoscope, permitting 
a visual angle of 110 degrees. When adequate tissue contact is made, tissue blanching will 
occur. If there is poor contact, however, then only free flowing blood is seen through the 
endoscope. Once the PV ostium is visualized, the next step is to use the optical fiber to target 
the laser arc at the appropriate tissue site. Correct identification of the ostium is critical to 
prevent formation of thrombus, which occurs when laser energy is focused on red blood 
cells. Keeping this in mind, the difference in the color of the light reflected is observed (seen 
as an arc) by the tissue and blood allows for assessment of contact. A red arc reflects contact 
with both tissue and blood, while green arc (Figure 7b) reflects balloon contact with tissue 
representing the target of ablation using this balloon technology. Once the arc is 
appropriately positioned to target the tissue of interest, a continuous 980-nm arc of laser 
energy is delivered. To avoid the overheating of myocardial tissue, sterile cooling fluid is 
circulated inside the balloon. Multiple arcs of ablation are applied to “stitch” individual 
lesions together to achieve a continuous circumferential lesion set.  
Studies utilizing visually guided balloon catheter ablation demonstrated long-term freedom 
from recurrence of atrial fibrillation at 67%, a rate comparable to that achieved with 
radiofrequency ablation (Reddy et al 2004). The delivery of deeper ablation energies in the 
pulmonary vein results in an increased risk of PV stenosis. The interface of the laser balloon 
catheter remains well outside the PV with the arc is projected on the ostium resulting in a 
decreased risk creating PV stenosis. 
To prevent esophageal injury intraoperative temperature monitoring of the esophagus is 
done. If the temperature rises then the arc is either advanced or retracted.In addition there is 
less incidence of pericardial tamponade because of the controlled energy delivery. (Reddy et 
al 2004). 
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Fig. 7a. Panel A visually guided balloon catheter displaying the green laser arc. In panel B 
Distal end of the catheter is shown. Catheter shaft endoscope and arc generator can be seen. 
(Reddy et al 2008). 
 
Fig. 7b. In this figure, the arc of laser can be seen.  The green light signifies the tissue and red 
light signifies the blood in the vein.  
8. High intensity focused ultrasound balloon system 
The High intensity focused ultrasound balloon system (HIFU) is a dual balloon in balloon 
design (Figure 8). The steerable HIFU catheter, a 10F catheter equipped with a 24mm 
diameter balloon, is advanced over the guidewire to the PV orifice, assisted by 
fluoroscopy and phased array intracardiac ultrasound (ICE) guidance. The anterior 
balloon is filled with fluid and the posterior with carbon dioxide. The interface created by 
the fluid and gas becomes the reflective interface of the ultrasound waves. The radially 
directed ultrasound energy is reflected forward to create a circumferential zone of 
concentrated ablative energy just beyond the face of the balloon. The mechanism of lesion 
formation is based on the conversion of the high intensity focused acoustic energy which 
causes molecular vibration that releases thermal energy in cardiac tissue. The steep tissue 
temperature gradient (2-5 °C per second) reaches 65-100°C with little heating of the 
adjacent tissue. (Okumura et al 2008 and Kennedy et al 2003) 
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The balloon technology allows complete, 360° delivery of circumferential energy around the 
PV orifice, which may simplify the procedure. The balloon catheter has a predictable 
focused zone with very rapid achievement of lethal tissue temperatures. Power titration 
may control energy delivery and limit its impact on collateral tissue. This also highlights the 
need for careful monitoring of device positioning within the context of the geometry of the 
vein and adjacent structures. Use of balloons larger than the PV orifice may prevent injury 
of phrenic nerve or distal pulmonary veins. 
       
Fig. 8 A. High-intensity focused ultrasound balloon ablation system. B: An  ICE catheter is 
placed within the coronary to visualize the HIFU catheter positioned at the ostium of the left 
inferior PV. (Reddy et al 2004). 
9. Cryothermal energy 
Cryotechnology has been used for cardiac ablation for three decades, but catheter based 
ablation has been a more recent development. Cryothermal energy produces lesions 
through hypothermic exposure, which is a very different mechanism of tissue injury as 
compared to heat ablation. Cryolesions are generated by application of a cryoprobe cooled 
with liquid nitrous oxide for 2 – 5 minutes (Stobie et al 2003). 
Progressive cooling of cardiac tissue slows down conduction and eventually blocks 
electrical activity when temperatures are reduced to 0 to -20°C. Permanent lesions are 
created when temperatures are reduced to -60 to -80 °C (Becker et al 2004). 
Applying the cryoprobe to the tissue surface causes the formation of a hemisphere of frozen 
tissue, or iceball. Ice crystals formed are seen both intracellularly and extracellularly. The 
primary mechanism of cell death is fatal structural change in subcellular organelles and the 
mitochondrial membrane. The electron transport system, which normally utilizes the 
mitochondrial membrane, stops working, this leads to irreversible mitochondrial damage, 
and ultimately cell death characterized by coagulative necrosis. Extracellular ice causes 
additional compression and distortion of adjacent cytoplasmic components and nuclei. 
Histpathologically RF lesions cause complete disruption of elastic fibers in comparison to 
normal appearing elastic fibers in cryolesions. Esophageal injury can occur in both RF and 
cryo, however cryo tissue injury is often benign and reversible. RF is compared with 
www.intechopen.com
 Electrophysiology – From Plants to Heart 
 
196 
Cryoablation in the table 2 below. Moreover, tensile strength of the tissue remains intact in 
cryolesions. The potential advantages of cryoablation over RF for ablation include a low risk 
of endocardial disruption, reduced incidence of thrombus formation, and stable adhesion of 
the catheter tip to the endocardium during freezing (Arora et al 2009). 
9.1 Cryoballoon 
New cryoballoon technology can safely and effectively electrically isolate the PVs (Avitall 
et al 2004). Avitall et al studied the original cryo balloon technology and found that after 
multiple consecutive cryolesions no PV stenosis was noted 3 months after ablation. After 
cryo ablation, PV electrograms were eliminated and tissue recovery exhibits no cartilage 
formation. Acute tissue hemorrhage and hemoptysis are short term complications of 
cryoablation. Arctic front cardiac cryoablation catheter developed by CryoCath is shown 
in the figure 9. It creates cryo lesions by delivering liquid N2O into the semi compliant 
balloon (23mm - 28mm diameter) and it is currently FDA approved for human PV 
isolation. 
 
Table 1. Comparison of cryoablation vs radiofrequency ablation (Yiu et al 2006). 
10. Virtual electrode and visualization catheter 
In the Virtual and visual electrode catheter a unipolar tip electrode is present with an 
endoscope circumferential to the tip it has a hood made up of a flexible elastopolymer 
membrane at the proximal end. This hood carries the circumferential light source bands for 
illumination. Consequently, this catheter provides the means of directly visualizing the 
target tissue that needs to be ablated. It is helpful in maintaining the contiguity of the lesions 
and also decreases the total procedure time. 
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Fig. 9. Cryoballoon. 
Additionally, ablation time can be controlled by visualizing blanching at the site where 
ablation is taking place, which is indicative of lesion formation (Figure 10 and 11). This 
catheter is constantly irrigated to evacuate the blood collection in the hood to increase the 
visibility of the tissue and also to cool the tip. Increased power leads to bubble formation in 
the hood and darkening of the tissue. Such lesions often result in steam pop. As a result, 
bubble formation and darkening of the tissue could be an indicator for lowering the power 
(Ahmed et al 2010). 
 
Fig. 10. Panel A: Visual field as seen through the endoscope. Pre ablation tissue is all red. 
Panel B: Post ablation tissue is pale as seen by the endoscopic visual field. * shows the 
previous ablation lesion with panel B demonstrating visualization of lesion contiguity 
(Ahmed et al 2011). 
A B
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Identified limitations of this catheter relate to technical difficulties of fixing the hood at the 
tissue interface, especially at rough surface of atrial tissue and edges around the pulmonary 
veins. The nature of the elastopolymer coating results in slippage of the catheter. It has also 
been seen to collapse, likely related to the force generated during lesion formation, requiring 
catheter replacement in certain cases (Ahmed et al 2011). 
 
Fig. 11 A. Blue lines indicate the saline irrigation, purple lines indicate radiofrequency; Red 
lines indicate the flowing blood .B, C, D Virtual and visual electrode catheter from different 
angles. Hood with source of illumination can be seen clearly in panel C, endoscope and 
electrodes in the center are clearly visible in panel B. (Ahmed et al 2011). 
Besides the technical limitations, current studies using this technology are limited by their 
small sample size, lack of application to atrial fibrillation and concerns over the volume of 
irrigation fluid delivered during the course of an ablation using this technology (Ahmed et 
al 2011). 
11. Microwave 
Microwave energy is an electromagnetic spectrum occupying the frequency range between 
500 MHz – 100 MHz. When this electromagnetic radiation comes in contact with the 
biological tissues, it causes bipolar molecules (particularly water molecules) to oscillate and 
rotate under the influence of alternating electromagnetic radiation. This oscillation results in 
the conversion into kinetic energy, and finally collision of molecules cause heat energy 
formation (Johnson et al 1972). This (microwave induced) heat forms in deeper tissues as 
compared to RF where heat flows down the tissue interface to the deeper tissues via 
conductive heating, decreasing as a function of distance (1/r4). Microwave energy excites 
deeper tissues resulting in deep high temperature and larger lesions. 
In fact, microwave induced scar seems to be the endpoint of two distinct pathways. The first 
pathway is the direct effect of microwave radiation, while the second is a result of ischemic 
damage. 
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Table 2.Comparison of Radiofrequency ablation and microwave ablations (Yiu et al 2006). 
12. Conclusion 
To date, many patients with refractory supraventricular tachyarrythmias have been 
successfully ablated without complications, however successful ablation of atrial fibrillation 
continues to pose unique problems to the cardiac electrophysiologist. While progress has 
been made on identification of the triggers and underlying substrate of atrial fibrillation, the 
tools necessary to isolate and ablate AF lags behind our knowledge of the mechanisms 
underlying this arrhythmia. The ideal catheter should possess the best mapping resolution 
to target the tissues of interest, create reliable transmural and contiguous lesions, and clearly 
discriminate between successful and unsuccessful lesion formation and maturation. 
Furthermore, the ideal catheter technology should be easily steered and adapt to the atrial 
anatomy reducing the procedure time. Further benefits of such an approach would be 
decreasing excessive exposure of radiation to the physician and the patient in the EP lab. So 
far, balloon devices seem to offer a unique promise, however lesion transmurality is still a 
question. 
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